Title : Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin.

Pub. Date : 2017 Sep

PMID : 28609310






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin. Doxorubicin solute carrier family 2 member 1 Homo sapiens
2 In the present study, we explored whether inhibiting the glucose transporter 1 (GLUT1) could restore the activity of adriamycin in breast cancer cell line MCF-7 resistant to adriamycin and the possible underlying mechanisms. Doxorubicin solute carrier family 2 member 1 Homo sapiens
3 In the present study, we explored whether inhibiting the glucose transporter 1 (GLUT1) could restore the activity of adriamycin in breast cancer cell line MCF-7 resistant to adriamycin and the possible underlying mechanisms. Doxorubicin solute carrier family 2 member 1 Homo sapiens
4 In the present study, we explored whether inhibiting the glucose transporter 1 (GLUT1) could restore the activity of adriamycin in breast cancer cell line MCF-7 resistant to adriamycin and the possible underlying mechanisms. Doxorubicin solute carrier family 2 member 1 Homo sapiens
5 In the present study, we explored whether inhibiting the glucose transporter 1 (GLUT1) could restore the activity of adriamycin in breast cancer cell line MCF-7 resistant to adriamycin and the possible underlying mechanisms. Doxorubicin solute carrier family 2 member 1 Homo sapiens
6 Adriamycin-resistant cell line MCF-7/ADR was selected stepwise from the parental MCF-7 cells and the level of GLUT1 was measured. Doxorubicin solute carrier family 2 member 1 Homo sapiens
7 Inhibition of the GLUT1 could partially restore the antineoplastic effects of adriamycin in the adriamycin-resistant MCF-7 cell line possibly through activating the AMPK, downregulating the mTOR pathway, and increasing the BAX translocation to mitochondria. Doxorubicin solute carrier family 2 member 1 Homo sapiens
8 Inhibition of the GLUT1 could partially restore the antineoplastic effects of adriamycin in the adriamycin-resistant MCF-7 cell line possibly through activating the AMPK, downregulating the mTOR pathway, and increasing the BAX translocation to mitochondria. Doxorubicin solute carrier family 2 member 1 Homo sapiens